ACHE and Alzheimer disease: However, during the progression of AD there is a 67% reduction in AChE [although the isoform G1 tends to increase, together with a reduction of the isoform G4 (Siek et al., 1990)] and a 165% increase in BuChE activity in the temporal lobe and hippocampus (Marucci et al., 2020).